Please assess the completion status of the following clinical trial:

Trial Title: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients, \>/= 18 years of age~* HBeAg-positive serologically proven chronic hepatitis B with or without cirrhosis~* Elevated serum ALT \> ULN (upper limit of normal) but \</= 10 x ULN~* Patients with no contra-indications to Pegasys therapy as detailed in the label~* Written informed consent where local regulations allow or require it~Exclusion Criteria:~* Patients should not receive concomitant therapy with telbivudine~* Co-infection with hepatitis A, hepatitis B or HIV~* Pregnant or breastfeeding women~* Patients with depression/mental diseases~* Neutrophil at baseline \> 90.000/mm3~* Abnormal T4 or TSH

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).